| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |